Primary Lung Cancer Treatment Guidelines (2022 Edition)
Primary Lung Cancer Treatment Guidelines (2022 Edition) I. Overview Primary lung cancer is the most common malignant tumor in China. From the perspective of pathology and treatment, lung…
Primary Lung Cancer Treatment Guidelines (2022 Edition) I. Overview Primary lung cancer is the most common malignant tumor in China. From the perspective of pathology and treatment, lung…
Regular review is required after lung cancer treatment. The purpose of review is to monitor the efficacy of treatment and to detect the recurrence and metastasis of tumor at an…
The prognosis of patients with lung cancer (including NSCLC and SCLC) is determined by a combination of clinicopathological characteristics of the patients. In addition, certain biochemical indicators (white blood cell…
Palliative care is a specific treatment modality that improves the quality of life of patients and families facing death from disease by controlling pain, relieving symptoms, and providing spiritual and…
The AJCC TNM staging system is used to select patients with stage T1 to 2N0 who are suitable for surgery.The TNM staging system should be used first in clinical studies…
Comprehensive treatment of patients with stage I NSCLC (1) Preferred surgical treatment includes lobectomy with systematic hilar and mediastinal lymph node dissection and partial lobectomy with selective lymph node dissection,…
With the increasing popularity of bronchoscopy in clinical applications, the following local therapies are available as treatment options for patients who cannot undergo surgery or radiotherapy: various bronchoscopy-mediated laser, high-frequency…
Drug therapy for lung cancer includes chemotherapy, molecular targeted therapy and immunotherapy. Chemotherapy is divided into neoadjuvant chemotherapy, adjuvant chemotherapy and palliative chemotherapy, which should be administered under the guidance…